Penicillin-resistant gonorrhea has been known clinically for over two decades as being responsive to ever-increasing doses of penicillin. Nowadays, the recommended treatment dose of penicillin is 25 times higher than it was 25 years ago, in order to get enough penicillin across the cell membrane to be effective.
Until recently, nevertheless, the gonococcus could not evade penicillin. But newer strains which are able to produce penicillinase permit the organism to resist all dosages. In addition, some of the penicillinase-producing strains se~n~, resistant to spectinomycin (the alternate drug of choice) in vivo though not in vitro.
The penicillinase which the gonococcus produces is beta-lactamase, an enzyme which has been known in N. influenzae since 1974. There is speculation that R-factors from H. influenzae were passed on plasmids to the N. gonorrhoeae, creating the new strain. Workers speculate that this occurred in the upper respiratory tract.
Between 20 and 40 per cent of the prosti-tutes in the Philippines are infected with penicillinase-producing gonorrheal strains. A smaller pool of these organisms has been found in Liverpool, England. While British authorities are moving to eradicate the organism there, Philippine agencies have not begun the task at this writing. Gonorrhea can be passed on in Ivy colleges and common brothels with equal abandon. There seems to be a slight decrease in incidence recently, but an estimated 2 million cases still occur in the United States each
year, according to public health officials.
The Center for Disease Control continues to recommend 1 g of probenecid followed one-half hour later with 4.8 million units of aqueous procaine penicillin intramuscularly (IM) as the initial treatment of choice for routine uncomplicated cases. Three to seven days later a culture should be obtained to prove bacteriologic cure. All post-treatment cultures which grow the gonococcus must be for beta-lactamase in the local state laboratory.
For who do not respond to penicillien or who are likely to be infected with a pcmciUinace-producing strain, a dose of 2 g of spectinomycin IM is advised.
